Nov 15, 2024
This Johnson & Johnson Analyst Begins Coverage on a Bullish Note: Price Target
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Goldman Sachs analyst David Roman initiated coverage on HealthEquity, Inc. (NASDAQ:HQY) with a Neutral rating and announced a price target of $108. HealthEquity shares closed at $95.70 on Thursday. See how other analysts view this stock.
- Wolfe Research analyst Alexandria Hammond initiated coverage on Pfizer Inc. (NYSE:PFE) with an Underperform rating and announced a price target of $25. Pfizer shares closed at $26.02 on Thursday. See how other analysts view this stock.
- Stifel analyst Brian Brophy initiated coverage on EMCOR Group, Inc. (NYSE:EME) with a Buy rating and announced a price target of $600. EMCOR shares closed at $498.11 on Thursday. See how other analysts view this stock.
- Redburn Atlantic analyst Harry Read initiated coverage on Insight Enterprises, Inc. (NASDAQ:NSIT) with a Buy rating and announced a price target of $220. Insight Enterprises shares closed at $152.63 on Thursday. See how other analysts view this stock.
- Wolfe Research analyst Alexandria Hammond initiated coverage on Johnson & Johnson (NYSE:JNJ) with an Outperform rating and announced a price target of $190. Johnson & Johnson shares closed at $151.87 on Thursday. See how other analysts view this stock.
Considering buying JNJ stock? Here’s what analysts think:
Read More:
